Molecular Biology Reports

, Volume 39, Issue 9, pp 9085–9093 | Cite as

The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats

  • Lina Wu
  • Yinghui Zhang
  • Xiaokun Ma
  • Na Zhang
  • Guijun QinEmail author


Reactive oxygen species production has recently been established as an essential contributor in the development of diabetic nephropathy (DN). Resveratrol, a natural anti-oxidants with biological activity, is known to be an activator of sirtuin1 (Sirt1). Forkhead transcription factor O1 (FoxO1) plays a role not only in regulating metabolism but also in oxidant stress. The present study was carried out to examine whether resveratrol had protective effect on diabetic kidney by modulation of the Sirt1/FoxO1 pathway. To investigate the effect of FoxO1 on oxidant stress, male Sprague–Dawley rats were injected with a single dose of 60 mg/kg streptozotocin (STZ) to induce diabetes. Here we show that the FoxO1 activity was significantly reduced and with a concomitant decrease in the expression of FoxO1 target gene, catalase in diabetic kidney. The FoxO1 downregulation correlated with an increase in the generation of malondialdehyde (MDA), a decrease in the activity of SOD and an increase in the expression of collagen IV and fibronectin proteins in renal cortex of diabetic rats. Treatment with the sirtuin agonist resveratrol, with an increase in the expression of Sirt1, significantly increased FoxO1 activity in diabetic kidney. This correlated with a decrease in the generation of MDA, an increase in the activity of SOD, a partial reversal of collagen IV and fibronectin proteins levels and more improved kidney pathological and biochemical indicators changes. Together these results indicate that it is characterized by decreased activity of FoxO1 in diabetic kidney. These data also suggest that modulation of the Sirt1/FoxO1 pathway may be a potentially useful therapeutic target for DN.


Resveratrol Forkhead transcription factor O1 Oxidative stress Silent information regulator 1 



This study was supported in part by the grants from the National Natural Science Funds of China (No. 51020009). We thank Mr. Shan-Feng Zhang and Mrs. Xiu-Hua Ren at Basic Medical College of Zhengzhou University for their insightful advice and technical assistance. We also thank Dr. Sheng-Jun Zhang at Medical College of Zhengzhou University for his insightful critique of the manuscript.


  1. 1.
    Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446–1454CrossRefPubMedGoogle Scholar
  2. 2.
    Ha H, Hwang IA, Park JH, Lee HB (2008) Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pr 82:S42–S45CrossRefGoogle Scholar
  3. 3.
    Wagener FA, Dekker D, Berden JH, Scharstuhl A, van der Vlag J (2009) The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 14:1451–1458CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ha H, Lee HB (2000) Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58:S19–S25CrossRefGoogle Scholar
  5. 5.
    Xia L, Wang H, Goldberg HJ, Munk S, Fantus IG et al (2006) Mesangial cell NADPH oxidase upregulation in high glucose is PKC dependent and required for collagen IV expression. Am J Physiol Renal Physiol 290:F345–F356CrossRefPubMedGoogle Scholar
  6. 6.
    Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B et al (2005) NOX4 NADPH oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616–39626CrossRefPubMedGoogle Scholar
  7. 7.
    Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ et al (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabete society. Diab Metab Res Rev 17:189–212CrossRefGoogle Scholar
  8. 8.
    Melhem MF, Craven PA, Derubertis FR (2001) Effects of dietary supplementation of α-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124–133PubMedGoogle Scholar
  9. 9.
    Schnackenberg CG, Wilcox CS (2001) The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59:1859–1864CrossRefPubMedGoogle Scholar
  10. 10.
    Daitoku H, Fukamizu A (2007) FOXO transcription factors in the regulatory networks of longevity. Jpn Biochem Soc 141:769–774Google Scholar
  11. 11.
    Sedding DG (2008) FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity? Bio Chem 389:279–283Google Scholar
  12. 12.
    Venkatesan B, Mahimainathan L, Das F, Ghosh-Choudhury N, Ghosh Choudhury G (2007) Downregulation of catalase by reactive oxygen species via PI3 Kinase/Akt signaling in mesangial cells. J Cell Physiol 211:457–467CrossRefPubMedGoogle Scholar
  13. 13.
    Kato M, Yuan H, Xu ZG, Lanting L, Li SL et al (2006) Role of the Akt/FoxO3a pathway in TGF-β1–mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17:3325–3335CrossRefPubMedGoogle Scholar
  14. 14.
    Zhang J (2006) Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397:519–527CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342CrossRefPubMedGoogle Scholar
  16. 16.
    Kitada M, Kume S, Imaizumi N, Koya D (2011) Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60:634–643CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Subauste AR, Burant CF (2007) Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab 293:E159–E164CrossRefPubMedGoogle Scholar
  18. 18.
    Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol induces growth arrest and Apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5:e15288CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196CrossRefPubMedGoogle Scholar
  20. 20.
    Park JM, Kim TH, Bae JS, Kim MY, Kim KS et al (2010) Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver. Biochem Biophys Res Commun 403:329–334CrossRefPubMedGoogle Scholar
  21. 21.
    Xu ZG, Li SL, Lanting L, Kim YS, Shanmugam N et al (2006) Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Kidney Int 69:512–519CrossRefPubMedGoogle Scholar
  22. 22.
    Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011–2015CrossRefPubMedGoogle Scholar
  23. 23.
    Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H et al (2005) NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288:F1144–F1152CrossRefPubMedGoogle Scholar
  24. 24.
    Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T et al (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101:10042–10047CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Giannakou ME, Partridge L (2004) The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14:408–412CrossRefPubMedGoogle Scholar
  26. 26.
    Guarente L (2007) Srtuins in aging and disease. Cold Spring Harb Symp Quant Biol 72:483–488CrossRefPubMedGoogle Scholar
  27. 27.
    Frescas D, Valenti L, Accili D (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280:20589–20595CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Lina Wu
    • 1
  • Yinghui Zhang
    • 1
  • Xiaokun Ma
    • 1
  • Na Zhang
    • 1
  • Guijun Qin
    • 1
    Email author
  1. 1.Division of Endocrinology, Department of Internal MedicineThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouPeople’s Republic of China

Personalised recommendations